Wound disinfection and repair

• US 5,622,725 A
• Filed: 06/28/1996
• Issued: 04/22/1997
• Est. Priority Date: 03/20/1992
• Status: Expired due to Fees

• Current Assignee: Alcide Corp (Ecolab, Inc.)
• Original Assignee: Alcide Corp (Ecolab, Inc.)
• Inventors: Kross, Robert D.
• Primary Examiner(s): PAK, JOHN D
• Application Number:
  US08/672,686
• Time in Patent Office: 298 Days
• Field of Search: 424/661-665, 422/28, 422/29, 422/37, 604/29, 604/53, 210/636
• US Class Current: 424/665
• CPC Class Codes: A01N 2300/00 Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
• CPC Class Codes: A01N 59/00 Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
• CPC Class Codes: A61K 33/20 Elemental chlorine; Inorganic compounds releasing chlorine

Abstract

Methods for preventing and treating microbial wound infections, especially of peritoneal cavity wounds including those having indwelling catheters, and enhancing wound repair while minimizing adhesions and scar formation involve the infusion or irrigation of the wound with a solution containing a pharmacologically acceptable carrier and chlorine dioxide in an amount ranging from about 5 ppm to 1000 ppm, and having a chlorine dioxide to chlorite ratio of at least 5:1. Typical solutions contain chlorine dioxide in isotonic saline and exhibit a pH of from about 5 to about 7.5. Sodium chlorite is employed in preferred embodiments.

Claims

1. A method for the treatment or prevention of microbial infections in a mammal having a peritoneal cavity catheter comprising infusing into the cavity or around the catheter an effective amount of a composition that is compatible with the peritoneal cavity comprising a pharmacologically acceptable carrier that is a peritoneal dialysis solution and chlorine dioxide in an amount ranging from greater than 125 ppm to about 1000 ppm, where the molar ratio of chlorine dioxide to any residual chlorite in the composition is at least 5:

1 and the pH of the composition is about 5 to 7.5.

2. A method according to claim 1 wherein the chlorine dioxide is produced by reacting an acid with an alkali metal chlorite.

3. A method according to claim 2 wherein the chlorine is sodium chlorite.

4. A method according to claim 2 wherein the acid is an organic acid selected from the group consisting of citric acid, malic acid, lactic acid, mandelic acid, tartaric acid, and mixtures thereof.

5. A method according to claim 3 wherein the acid is lactic acid.

6. A method for irrigating a peritoneal cavity wound to disinfect the wound and promote healing, comprising infusing the wound with a composition that is compatible with the peritoneal cavity comprising greater than 125 ppm to 1000 ppm chlorine dioxide in a pharmaceutically acceptable carrier having a pH of about 5 to about 7.5, provided that the molar ratio of chlorine dioxide to chlorite in the composition is at least 5:

1.

7. A method according to claim 6 wherein the wound is a surgical wound.

8. A method according to claim 7 wherein the composition contains from greater than 125 to about 250 ppm chlorine dioxide.

9. A method according to claim 7 wherein the composition contains from greater than 125 to about 600 ppm chlorine dioxide.

10. A method according to claim 7 wherein the wound contains an indwelling catheter.

11. A method according to claim 6 wherein the composition contains chlorine dioxide generated by reacting up to about 0.25% of a water-soluble chlorite selected from the group consisting of alkali metal chlorites, alkaline earth metal chlorites, and mixtures thereof, with a sufficient amount of acid to yield a chlorine dioxide concentration of from greater than 125 to 600 ppm.

12. A method according to claim 11 wherein the chlorite is sodium chlorite.

13. A method according to claims 11 wherein the chlorine dioxide concentration is from about 150 to 600 ppm.

14. A method according to claim 6, wherein the chlorine dioxide is generated by reaction of an acid with a water-soluble chlorite selected from the group consisting of alkali metal chlorites, alkaline earth metal chlorites, and mixtures thereof.

15. A method according to claim 14 wherein the acid is a mineral acid selected from the group consisting of sulfuric acid, hydrochloric acid, and phosphoric acid.

16. A method according to claim 14 wherein the acid is an organic acid selected from the group consisting of citric acid, malic acid, lactic acid, mandelic acid, tartaric acid, and mixtures thereof.

17. A method according to claim 14 wherein the composition further comprises isotonic chloride ion.

18. A method according to claim 14 wherein the reaction is carried out in the presence of a heat-activated saccharide compound prepared by heating a saccharide selected from the group consisting of glucose, galactose, mannose, ribose, rhamnose, lactose, sucrose, maltose, and mixtures thereof, to a temperature of from about 50°

C. to about 150°

C. for at least about 1 minute.

19. A method for treating or preventing a microbial infection in the peritoneal cavity of a mammal comprising infusing into the cavity an effective amount of a composition comprising chlorine dioxide in a pharmacologically acceptable carrier, wherein the molar ratio of chlorine dioxide to chlorite in the composition is at least 5.1, wherein the composition contains from greater than 125 ppm to about 1000 ppm chlorine dioxide and is compatible with the peritoneal cavity.

20. A method according to claim 19 wherein the chlorine dioxide in the composition is produced by the reaction of a chlorine dioxide generating compound and an acid.

21. A method according to claim 20 wherein the chlorine dioxide generating compound is a water-soluble chlorite selected from the group consisting of an alkali metal chlorite, an alkaline earth metal chlorite, and mixtures thereof.

22. A method according to claim 21 wherein the chlorine dioxide in the composition is produced by a process selected from the group consisting of:

(a) reaction of a chlorite with a mineral acid and adjustment of the pH to about 5 to about 7.5;

(b) reaction of a chlorite with an organic acid having a pK of from about 2.8 to about 4.2; and

(c) reaction of a chlorite with a saccharide, which has been heat-activated by heating the saccharide to a temperature of from about 50°

C. to about 150°

C. for at least about 1 minute, in a solution in the presence of an organic acid having a pK of from about 2.8 to about 4.2 and a pH below about 5.5.

23. A method according to claim 22 wherein the organic acid is lactic acid.

24. A method according to claim 22 wherein the saccharide is selected from the group consisting of glucose, galactose, mannose, ribose, rhamnose, lactose, sucrose, maltose, and mixtures thereof.

25. A method according to claim 22 wherein the chlorite is sodium chlorite.